BOLALARDA SURUNKALI BUYRAK KASALLIGI RIVOJLANIShINING IMMUNPATOGENETIK XUSUSIYATLARI (adabiyotlar sharxi)
Abstrakt
Maqsad: bolalardagi me'yoriy va patologik jarayonlarda, xususan surunkali buyrak kasalligi immunpatogenetik rivojlanishida sitokin profili boshqaruvi ahamiyatini aniqlash. Xulosa: sitokin mediatorlarining turli xil xususiyatlari organizmni yuqumli agentlardan himoya qilish va to‘qimalarni tiklashga xizmat qiladi. Birinchi navbatda, sitokinlar mahalliy himoya jarayonlarining rivojlanishini tartibga soladi, yallig‘lanish reaksiyasining shakllanishini sodir etadi. Shuning uchun ham yallig‘lanishni qo‘llovchi va yallig‘lanishga qarshi sitokinlarning tarkibi va ularning nisbatini yallig‘lanish jarayoni va fibrozning kuchayishini eng ob'ektiv ko‘rsatkichlari deb hisoblash mumkin. Sitokin tizimidagi nomutanosiblikni bashorat qilish, surunkali buyrak kasalligining biomarkeri sifatida, kasallikni kechishi va davolash samaradorligini baholashda qo‘llanilishi mumkin. Adabiyot ma'lumotlarini tahlil qilish surunkali buyrak kasalliklarida sitokin holatini o‘rganishning ilmiy va amaliy ahamiyatini yoritib berdi.
Kalit so'zlar:
Mualliflar haqida
Adabiyotlar ro'yxati
Ilkhamdzhan K, Lola R, Gulshan I, Nigora I, Gulnoza Y, Umida K. Arterial Hypertension in Children with Chronic Kidney Diseases. Am J Pediatr 2020;6:109. https://doi.org/10.11648/j.ajp.20200602.18.
Karimjanov I, Rakhmanova L, Israilova UKN, Sadikova N. A Highly Effective Algorithm For Predicting Chronic Kidney Disease In Children On The Background Of Atopia. Int J Adv Sci Technol 2020;29:3389–94.
Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, et al. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines for Chronic Kidney Disease in Children and Adolescents: Evaluation, Classification, and Stratification. Pediatrics 2003;111:1416–21. https://doi.org/10.1542/peds.111.6.1416.
Ifuku M, Miyake K, Watanebe M, Ito K, Abe Y, Sasatomi Y, et al. Various Roles of Th Cytokine mRNA Expression in Different Forms of Glomerulonephritis. Am J Nephrol 2013;38:115–23. https://doi.org/10.1159/000353102.
Suárez-Fueyo A, Bradley SJ, Klatzmann D, Tsokos GC. T cells and autoimmune kidney disease. Nat Rev Nephrol 2017;13:329–43. https://doi.org/10.1038/nrneph.2017.34.
Oradova A.Sh., Ustenova G.O., Stabaeva G.S. Methods of cytokine research (review article) 2014:84–7.
Su H, Lei C-T, Zhang C. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update. Front Immunol 2017;8:405. https://doi.org/10.3389/fimmu.2017.00405.
Alwahaibi N, Alissaei H, Al-Kalbani A, Alabri N, Allawati Z, Albalooshi M. Evaluation of interleukin-2, interleukin-8, and tumor necrosis factor-like weak inducer of apoptosis in hemodialysis and renal transplant patients and healthy controls. Saudi J Kidney Dis Transplant 2016;27:1123. https://doi.org/10.4103/1319-2442.194594.
Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, et al. IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly. Kidney Int 2005;67:1216–33. https://doi.org/10.1111/j.1523-1755.2005.00200.x.
Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity 2013;39:1003–18. https://doi.org/10.1016/j.immuni.2013.11.010.
Sinuani I, Beberashvili I, Averbukh Z, Sandbank J. Role of IL-10 in the progression of kidney disease. World J Transplant 2013;3:91. https://doi.org/10.5500/wjt.v3.i4.91.
Huang H.Y., H.Y.Huang, J. Clin. Interleukin (IL)-Ip regulation of Il-lp and IL-1 receptor antagonist expression in cultured human endometrial stromal cells. Endocrinol 2009:1387–93.
Khatri S, Bajeer IA, Tresa V, Hashmi S, Mubarak M, Lanewala AA. Short-term outcome of clinical and histopathologic variants of mesangiocapillary glomerulonephritis in children: A retrospective analysis from a tertiary care center. JPMA J Pak Med Assoc 2018;68:1199–204.
Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza FC, Mezzano SA, et al. Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2012;2:139–274. https://doi.org/10.1038/kisup.2012.9.
I. V. Zorin, A. A. Vyalkova, E. V. Gunkova, L. V. Kutsenko, S. V. Plotnikova, S. A. Tchesnokova, S. M. Konnova. Role of cytokines and growth factors in formation and progression of chronic kidney disease in children n.d.
Liu Q, Ding JL. The molecular mechanisms of TLR-signaling cooperation in cytokine regulation. Immunol Cell Biol 2016;94:538–42. https://doi.org/10.1038/icb.2016.18.
Paunova S.S. Children’s nephrology.Textbook. Moscow. MEDpress-inform 2018:466–7.
Drannik GN, Driyanskaya VE, Gajsenyuk FZ, Rudenko MY, Stepanova NM, Bagdasarova IV. Factors of intercellular cooperation in the immunogenesis of pyelonephritis. Immunol Allergol Infektologiya 2013;1:13–9.
Utc I.A., Zaharova N.B., Kostina M.L. Modern aspects of intercellular interactions and their role in the genesis of tubulointerstitial nephropathies. Saratovskii nauchno-medicinskii zhurnal 2007;3:44–9.
Morozov D.A., Morrison V.V., Morozova O.L., Lakomova D.Yu. Pathogenetic principles and modern possibilities of early diagnosis of nephrosclerosis in children with vesicoureteral reflux. Saratovskii nauchno-meditsinskii zhurnal 2011;7:151–7.
Korenkov DG, Pavlov AL. CYTOKINES IN THE DIAGNOSIS OF THE SEVERITY OF THE ACTIVE PHASE OF CHRONIC PYELONEPHRITIS. Her Urol 2017;5:14–21. https://doi.org/10.21886/2308-6424-2017-5-3-14-21.
Ortega L. Role of cytokines in the pathogenesis of acute and chronic kidney disease, glomerulonephritis, and end-stage kidney disease. Int J Interferon Cytokine Mediat Res 2010:49. https://doi.org/10.2147/IJICMR.S10111.
Simões E Silva AC, Valério FC, Vasconcelos MA, Miranda DM, Oliveira EA. Interactions between Cytokines, Congenital Anomalies of Kidney and Urinary Tract and Chronic Kidney Disease. Clin Dev Immunol 2013;2013:1–14. https://doi.org/10.1155/2013/597920.
Merkodanova Yu.A. Urine cytokine profile in various etiopathogenetic variants of chronic pyelonephritis in children. Saratovskij nauchno-meditsinskij zhurnal 2011;7:901–4.
Hvorostov I.N., Zorkin S. N., Smirnov E.I. The value of determining the levels of cytokines in obstructive uropathies in children. Vestnik 2005;GMU:45–9.
Tullus K, Sjöberg P. Epidemiological Aspects of P-Fimbriated E. coli.: II. Variations in Incidence of E. coli Infections in Children Attending a Neonatal Ward. Acta Paediatr 1986;75:205–10. https://doi.org/10.1111/j.1651-2227.1986.tb10185.x.
Bychkovskih V.A. Assessment of the level of cytokines in the blood serum of patients with chronic pyelonephritis of a single kidney in the early postoperative period. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e» (Kursk Scientific and Practical Bulletin «Man and His Health») 2011:42–5.
Zaharova N.B., Grazhdanov R.A., Ponukalin A.N., Inozemceva N.D. Rossolovskij A.N.Diagnostic value of pro- and anti-inflammatory citokines in urine at an yexacerbation of chronic calculous pyelonephritis. Byulleten’ medicinskih Internet-konferencij (Internet Medical Bulletin) 2013;4:835–8.
López-Novoa JM, Rodríguez-Peña AB, Ortiz A, Martínez-Salgado C, López Hernández FJ. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications. J Transl Med 2011;9:13. https://doi.org/10.1186/1479-5876-9-13.
Slobodian EI, Kaladze NN, Govdalyuk AL. URINE CYTOKINES ARE NONINVASIVE MARKERS OF CLINICAL AND LABORATORY REMISSION IN CHILDREN WITH CHRONIC PYELONEPHRITIS. Nephrol St-Petersburg 2017;21:73–82. https://doi.org/10.24884/1561-6274-2017-21-2-73-82.
Renata Y, Jassar H, Katz R, Hochberg A, Nir R-R, Klein-Kremer A. Urinary concentration of cytokines in children with acute pyelonephritis. Eur J Pediatr 2013;172:769–74. https://doi.org/10.1007/s00431-012-1914-2.
Lipiec K, Adamczyk P, Świętochowska E, Ziora K, Szczepańska M. L-FABP and IL-6 as markers of chronic kidney damage in children after hemolytic uremic syndrome. Adv Clin Exp Med 2018;27:955–62. https://doi.org/10.17219/acem/70567.
Karzakova LM, Kudryashov SI, Shestipalova MV, Leontyeva EV. DETERMINING OF CYTOKINE LEVELS IN THE URINE IN CLINICAL PRACTICE. Russ Clin Lab Diagn 2019;64:287–93. https://doi.org/10.18821/0869-2084-2019-64-5-287-293.
Beglyarov RO, Оглы БРО. Proand anti-inflammatory cytokines in children with various clinical forms of chronic glomerulonephritis. Kazan Med J 2017;98:943–8. https://doi.org/10.17750/KMJ2017-943.
Zwiech R. Predictive Value of Conjointly Examined IL-1ra, TNF-R I, TNF-R II, and RANTES in Patients with Primary Glomerulonephritis. J Korean Med Sci 2013;28:261. https://doi.org/10.3346/jkms.2013.28.2.261.
Zhiznevskaya I.I., Hmelevskaya I.G. Peculiarities of the cytokine profile in glomerulopathy in children. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e» (Kursk Scientific and Practical Bulletin «Man and His Health») 2013;2:261–7.
Anders H-J. Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease. J Am Soc Nephrol 2016;27:2564–75. https://doi.org/10.1681/ASN.2016020177.
Sakthirajan R, Dhanapriya J, Nagarajan M, Dineshkumar T, Balasubramaniyan T, Gopalakrishnan N. Crescentic infection related glomerulonephritis in adult and its outcome. Saudi J Kidney Dis Transplant 2018;29:623–9. https://doi.org/10.4103/1319-2442.235169.
Kolesnyk M, Driyanska V, Velichko M, Drannik G, Savchenko V. PECULIARITIES OF CYTOKINES AND THEIR PROGNOSTIC VALUE IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS. Ukr J Nephrol Dial 2017:28–35. https://doi.org/10.31450/ukrjnd.3(39).2013.04.
Latifova NF, Dzhafarova GA, Efendiev AM, Bagirova SA, Gafarov IA. STUDY OF CYTOKINES AND ANTIMICROBIAL PEPTIDES IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Современные Проблемы Науки И Образования Mod Probl Sci Educ 2019:57–57. https://doi.org/10.17513/spno.29031.
Couser WG. Basic and translational concepts of immune-mediated glomerular diseases. J Am Soc Nephrol JASN 2012;23:381–99. https://doi.org/10.1681/ASN.2011030304.
Murkamilov I, Aitbae K, Fomin V, Murkamilova Z, Sabirov I, Rayimzhanov Z, et al. Pro-inflammatory cytokines in patients with chronic kidney disease: interleukin-6 in focus. Russ Arch Intern Med 2019;9:428–33. https://doi.org/10.20514/2226-6704-2019-9-6-428-433.
Malyshev M.E., Bel’skih O.A., Sorokina A.A., Zubor O.I. The information content of the cytokine profile of blood serum and salivary fluid in patients with chronic kidney disease. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e» (Kursk Scientific and Practical Bulletin «Man and His Health») 2016:44–9.
Rakhmanova L, Rakhmanov A. ASSESSMENT OF IMMUNOPATHOLOGICAL DEVELOPMENTS IN CHILDREN WITH NEPHROTIC SYNDROME WITH BACKGROUND PATHOLOGY. Int J Sci Pediatr 2022:11–7. https://doi.org/10.56121/2181-2926-2022-8-11-17.
Rakhmanova L.K., Savenkova N.D., Iskandarova I.R. Immune-hematological risks of progression of chronic kidney disease in children with lymphatic diathesis. Journal of Xi`an Shiyou University, Natural Science Edition 2020;16.
Qanday qilib iqtibos keltirish kerak
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
